Form 4: Accuray Director Granted 56,603 RSUs

Accuray Inc. Director Beverly A. Huss received a grant of 56,603 Restricted Stock Units, which are set to vest in November 2026.

Summary

• Beverly A. Huss, a Director of Accuray Inc. (ARAY), was granted 56,603 Restricted Stock Units (RSUs).
• Each RSU represents a contingent right to receive one share of Accuray's common stock.
• The RSUs were granted on November 28, 2025, with a conversion or exercise price of $0.
• The entire grant of 56,603 RSUs will vest 100% on November 13, 2026.
• Following this transaction, Beverly A. Huss beneficially owns 56,603 derivative securities (RSUs).

Sentiment

Score: 6

Explanation: Slightly positive as it indicates alignment of director interests with shareholders through equity compensation, a standard governance practice.

Positives

• The grant of Restricted Stock Units to a director aligns their interests with those of common shareholders, incentivizing long-term performance.
• Equity-based compensation is a common practice to attract and retain qualified board members.

Negatives

• No direct negatives are apparent from this routine compensation filing.

Risks

• No specific risks are mentioned in this Form 4 filing.

Future Outlook

This filing does not provide a future outlook for the company's performance or strategy. It solely reports an insider transaction.

Management Comments

• No direct management comments or notable quotes are included in this Form 4 filing.

Industry Context

The granting of Restricted Stock Units (RSUs) to directors is a standard practice in corporate governance across various industries, including medical technology, to align the interests of board members with long-term shareholder value. This type of equity compensation is a common component of director remuneration packages.

Comparison to Industry Standards

• The grant of Restricted Stock Units to a director is a standard form of equity compensation, widely used by publicly traded companies to incentivize long-term performance and align director interests with shareholders.
• While specific grant sizes vary by company size, industry, and individual contribution, the mechanism itself is consistent with global benchmarks for executive and director compensation.
• No specific comparable companies or projects are detailed in this filing to allow for a direct quantitative comparison of the grant size.

Related Party Transactions

• This filing reports an equity grant to a director, which is a form of compensation and an insider transaction. It does not detail any special related party dealings outside of standard compensation practices.

Stakeholder Impact

• Shareholders: The grant of RSUs to a director aligns the director's financial interests with long-term shareholder value, potentially leading to more shareholder-centric decision-making.
• Employees: No direct impact on employees is indicated by this filing.
• Customers: No direct impact on customers is indicated by this filing.
• Suppliers: No direct impact on suppliers is indicated by this filing.
• Creditors: No direct impact on creditors is indicated by this filing.

Next Steps

• The Restricted Stock Units are scheduled to vest on November 13, 2026, at which point they will convert into shares of common stock.

Key Dates

Keywords

Accuray Inc., ARAY, Restricted Stock Units, RSU, Insider Transaction, Director Compensation, Equity Grant, Beverly A. Huss, SEC Form 4